Product Information

FT ASPIRIN 325 MG TABLET is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.0164 per EA under NDC 70677118901. Its NADAC has been published 141 times since Dec 13, 2023.

FT ASPIRIN 325 MG TABLET

Aspirin
$0.0164per EA
OTC

Strength

325 mg/1

NDC

70677118901

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ASPIRIN

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M013

On Market Since

6/12/2023

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Decreased Platelet Aggregation
Decreased Prostaglandin Production
Nonsteroidal Anti-inflammatory Drug
Platelet Aggregation Inhibitor

Price Statistics

The NADAC for FT ASPIRIN 325 MG TABLET has been published 141 times since Dec 13, 2023, and over the history we have for it it has risen 18.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0164 per EA
All-time high$0.0166 (Jul 10, 2024)
All-time low$0.0139 (Dec 13, 2023)
52-week high$0.0164
52-week low$0.0154
Median price$0.0158
Average price$0.0156
Largest weekly change+7.8% (Apr 17, 2024)
Weeks tracked141
Tracking sinceDec 13, 2023

Price History

1W

+2.1%

1M

+2.1%

3M

+2.5%

6M

+5.1%

1Y

+6.9%

3Y

N/A

5Y

N/A

All

+18.0%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 27% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of FT ASPIRIN 325 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for FT ASPIRIN 325 MG TABLET, manufactured by Strategic Sourcing Services LLC, is $0.0164 per EA (NDC 70677118901), effective Aug 19, 2026.

How has the price of FT ASPIRIN 325 MG TABLET changed over time?

Over the history we have for it, the NADAC for FT ASPIRIN 325 MG TABLET has risen 18.0%. It has been tracked across 141 weekly CMS publications since Dec 13, 2023.

What are the highest and lowest recorded NADAC prices for FT ASPIRIN 325 MG TABLET?

Since Dec 13, 2023, the NADAC for FT ASPIRIN 325 MG TABLET has ranged from a low of $0.0139 (Dec 13, 2023) to a high of $0.0166 (Jul 10, 2024), with a median of $0.0158 per EA.

Are there cheaper alternatives to FT ASPIRIN 325 MG TABLET?

Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QC ASPIRIN 325 MG TABLET, is $0.0121 per EA — about 27% below FT ASPIRIN 325 MG TABLET.

Who manufactures FT ASPIRIN 325 MG TABLET?

FT ASPIRIN 325 MG TABLET (NDC 70677118901) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.